The Effects of a Personalized Sleep Improvement App From SleepScore Labs
CompletedNAResults postedLast updated 26 November 2025
What this trial tests
NA trial testing Dein Schlaf. Dein Tag. sleep improvement application powered by SleepScore in Health Behavior in 637 participants. Completed in 15 August 2023.
18 and older, any sex, with Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in SF B Sleep Quality From Baseline to 6 WeeksPrimary· Baseline and 6 weeks
SF B Sleep Quality (SQ): SF B (Görtelmeyer). Range 1-5; higher = better sleep quality.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
2.73
± 0.51
Allocation to Waitlist Control Group
2.73
± 0.56
6-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
2.98
± 0.51
Allocation to Waitlist Control Group
2.81
± 0.60
Change in SF B Sleep Quality From Baseline to 12 WeeksPrimary· Baseline and 12 weeks
SF B Sleep Quality (SQ): SF B (Görtelmeyer). Range 1-5; higher = better sleep quality.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
2.75
± 0.50
Allocation to Waitlist Control Group
2.73
± 0.56
12-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
3.05
± 0.51
Allocation to Waitlist Control Group
2.86
± 0.64
Changes in Overall Sleep Problems From Baseline to 6 WeeksSecondary· Baseline and 6 weeks
PSQI Global Score: Range 0-21; higher = worse sleep quality; conventional cutoff \>5 indicates poor sleep.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
8.54
± 3.02
Allocation to Waitlist Control Group
8.47
± 3.37
6-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
7.14
± 2.65
Allocation to Waitlist Control Group
8.24
± 3.57
Changes in Feeling of Being Refreshed in the Morning From Baseline to 6 WeeksSecondary· Baseline and 6 weeks
SF B Feeling Refreshed (GES): SF B GES subscale. Range 1-5; higher = better feeling of being refreshed.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
2.68
± 0.63
Allocation to Waitlist Control Group
2.68
± 0.77
6-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
2.86
± 0.70
Allocation to Waitlist Control Group
2.75
± 0.78
Changes in Health Measures From Baseline to 6 WeeksSecondary· Baseline and 6 weeks
SF 12 (PCS \& MCS): Norm based T scores (mean 50, SD 10); higher = better health status. We report PCS and MCS separately.
Baseline physical wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
52.70
± 6.62
Allocation to Waitlist Control Group
51.01
± 8.76
6-week follow-up physical wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
53.13
± 8.09
Allocation to Waitlist Control Group
50.45
± 9.11
Baseline mental wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
37.31
± 6.15
Allocation to Waitlist Control Group
38.16
± 6.68
6-week follow-up mental wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
38.56
± 7.16
Allocation to Waitlist Control Group
38.77
± 6.69
Changes in Mental Health Stress From Baseline to 6 WeeksSecondary· Baseline and 6 weeks
PSS 10: 10 items scored 1-5; total 10-50; higher = more stress.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
28.62
± 6.34
Allocation to Waitlist Control Group
28.87
± 6.35
6-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
27.27
± 6.97
Allocation to Waitlist Control Group
28.62
± 6.58
Changes in Overall Sleep Problems From Baseline to 12 WeeksSecondary· Baseline and 12 weeks
PSQI Global Score: Range 0-21; higher = worse sleep quality; conventional cutoff \>5 indicates poor sleep.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
8.50
± 3.02
Allocation to Waitlist Control Group
8.41
± 3.35
12-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
7.11
± 2.77
Allocation to Waitlist Control Group
7.88
± 3.50
Changes in Feeling of Being Refreshed in the Morning From Baseline to 12 WeeksSecondary· Baseline and 12 weeks
SF B Feeling Refreshed (GES): SF B GES subscale. Range 1-5; higher = better feeling of being refreshed.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
2.72
± 0.63
Allocation to Waitlist Control Group
2.67
± 0.73
12-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
2.98
± 0.74
Allocation to Waitlist Control Group
2.77
± 0.78
Changes in Health Measures From Baseline to 12 WeeksSecondary· Baseline and 12 weeks
SF 12 (PCS \& MCS): Norm based T scores (mean 50, SD 10); higher = better health status. We report PCS and MCS separately.
Baseline physical wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
52.88
± 6.59
Allocation to Waitlist Control Group
51.22
± 8.74
12-week follow-up physical wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
53.08
± 7.78
Allocation to Waitlist Control Group
51.61
± 8.75
Baseline mental wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
37.80
± 6.04
Allocation to Waitlist Control Group
38.29
± 6.61
12-week follow-up mental wellbeing SF-12
Group
Value
95% CI
Allocation to Sleep Improvement App
39.27
± 6.53
Allocation to Waitlist Control Group
38.19
± 6.85
Changes in Mental Health Stress From Baseline to 12 WeeksSecondary· Baseline and 12 weeks
PSS 10: 10 items scored 1-5; total 10-50; higher = more stress.
Baseline
Group
Value
95% CI
Allocation to Sleep Improvement App
28.05
± 6.18
Allocation to Waitlist Control Group
28.81
± 6.40
12-week follow-up
Group
Value
95% CI
Allocation to Sleep Improvement App
25.60
± 6.57
Allocation to Waitlist Control Group
27.48
± 6.71
Sponsor's own description
The study is a single-blinded randomized waitlist controlled trial that aims to assess changes in objective and self-report sleep improvement through use of a dynamic and personalized sleep improvement smartphone app and advice engine in those with poor sleep (i.e., subclinical threshold insomnia) when compared to a waitlist control group after 6 weeks and 12 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT)
· NA
· recruiting
NCT07248904 — The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea
· NA
· recruiting
NCT07224412 — A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
· NA
· recruiting
NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals
· NA
· recruiting
NCT07226271 — Consumer Perceptions of Alcoholic Beverages
· NA
· recruiting
Other ResMed trials
Trials by the same sponsor.
NCT07400861 — Study of Min-Max APAP Recommender Tool
· NA
· not yet recruiting
NCT07099183 — Nyx3 Data Collection Study
· not yet recruiting
NCT06930404 — Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea
· not yet recruiting
NCT05255744 — Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol
· NA
· unknown
NCT03924817 — Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstru
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ResMed
Last refreshed: 26 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05195359.